首页> 外文期刊>Pain research & management: the journal of the Canadian Pain Society = journal de la socie?te? canadienne pour le traitement de la douleur >Injection of Lidocaine Alone versus Lidocaine plus Dexmedetomidine in Impacted Third Molar Extraction Surgery, a Double-Blind Randomized Control Trial for Postoperative Pain Evaluation
【24h】

Injection of Lidocaine Alone versus Lidocaine plus Dexmedetomidine in Impacted Third Molar Extraction Surgery, a Double-Blind Randomized Control Trial for Postoperative Pain Evaluation

机译:单独注射利多卡因与Lidocaine加上右甲丁染素在受影响的第三磨牙萃取手术中,一种双盲随机控制试验,可用于术后疼痛评价

获取原文
获取外文期刊封面目录资料

摘要

Objectives. Administration of medications such as dexmedetomidine as a topical anesthetic has been suggested in the pain control in dentistry. This double-blind randomized control trial study evaluated postoperative pain and associated factors following impacted third molar extraction surgery. Lidocaine alone was taken as the control and lidocaine plus dexmedetomidine as the intervention. Materials and Methods. Forty patients undergoing mandibular third molar extraction entered the study and were randomly allocated to the control and interventional groups. 0.15?ml of dexmedetomidine was added to each lidocaine cartridge and the drug concentration was adjusted to 15?μg for the intervention group while only lidocaine was used in the control group. A visual analog scale was used to measure and record pain levels at the end of the surgery and 6, 12, and 24 hours after the surgery and number of painkillers taken by the patients after the surgery was also recorded. Results. Pain scores of the intervention group decreased significantly during the surgery and also 6, 12, and 24 hours after the surgery compared to the control group. The pain score was correlated significantly with our intervention during the surgery and also 6 and 12 hours after that (all P value 0 . 05 ). Conclusion. In patients undergoing molar surgery, administration of a combination of dexmedetomidine and lidocaine is beneficial for the pain control. Clinical Relevance. Compared to the injection of lidocaine alone, combination of dexmedetomidine and lidocaine can be used for a better pain control in molar surgeries.
机译:目标。在牙科疼痛对照中提出了诸如Dexmedetomidine作为局部麻醉剂的药物施用药物。这种双盲随机对照试验研究评估了术后疼痛和相关因素,后来第三摩尔提取手术。单独的Lidocaine被视为控制和Lidocaine加上右甲酰过甲酰胺作为干预。材料和方法。正在进行颌骨第三摩尔提取的四十名患者进入该研究,随机分配给对照和介入群体。向每个利多卡因盒中加入0.15毫升甲尿嘧啶胺,并将药物浓度调节至15μg的干预组,同时在对照组中使用LIDocaine。目视模拟规模用于测量和记录手术结束时的疼痛水平和患者在手术后患者手术和止痛药的数量的痛苦水平。结果。与对照组相比,手术期间,止痛组的疼痛评分显着下降,同时6,12和24小时,术后24小时减少。疼痛评分随着手术期间的干预和6和12小时而显着相关(所有P值0。05)。结论。在接受磨牙手术的患者中,德森甲酰胺和利多卡因的组合施用对疼痛控制有益。临床相关性。与单独的利多卡因注射相比,Dexmedetomidine和Lidocaine的组合可用于摩尔手术中的更好的疼痛控制。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号